Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2021

Feb 4, 2021

29745_dirs_2021-02-03_9553f4ce-9823-4e15-8103-3da9795f6f2a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-02-01

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-01 Common Stock M 75387 Acquired 343639 Direct
2021-02-01 Common Stock F 33738 $207.97 Disposed 309901 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-01 Restricted Stock Unit $ M 75387 Disposed 2021-02-01 Common Stock (75387.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6931 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.